University of Groningenfounded in 1614  -  top 100 university
Close
Research Research database

Pharmacotherapy and Pharmaceutical Care

University of Groningen > Faculty of Science and Engineering > Faculty Board FSE > FSE Research > Groningen Research Institute of Pharmacy > Pharmacotherapy and Pharmaceutical Care

Advanced
Advanced

Reset

to
101 - 150 out of 1,207Page size: 50
  1. 2015
  2. de Vries, F. M., Voorham, J., Hak, E., & Denig, P. (2015). Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients. Current Medical Research and Opinion, 31(12), 2197-2206. https://doi.org/10.1185/03007995.2015.1092126
  3. van der Meer, H. G., Wouters, H., van Hulten, R., Pras, N., & Taxis, K. (2015). Decreasing the load? Is a Multidisciplinary Multistep Medication Review in older people an effective intervention to reduce a patient's Drug Burden Index? Protocol of a randomised controlled trial. BMJ Open, 5(12), [e009213]. https://doi.org/10.1136/bmjopen-2015-009213
  4. Ivanova, S. A., Fedorenko, O. Y., Freidin, M. B., Alifirova, V. M., Zhukova, N. G., Zhukova, I. A., Al Hadithy, A. F. Y., Brouwers, J. R. B. J., Bokhan, N. A., Wilffert, B., & Loonen, A. J. M. (2015). Dissimilar mechanistic background of peripheral and orofacial hyperkinesia in patients with Parkinson’s disease and levodopa-induced dyskinesia. Physiology and Pharmacology, 19(4), 216-221.
  5. van Hunsel, F., van de Koppel, S., & van Puijenbroek, E. (2015). Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Product. Drug Safety - Case Reports, 2(1), [14]. https://doi.org/10.1007/s40800-015-0016-2
  6. Ivanova, S. A., Fedorenko, O. Y., Freidin, M. B., Alifirova, V. M., Zhukova, N. G., Zhukova, I. A., Al Hadithy, A. F. Y., Brouwers, J. R. B. J., Bokhan, N. A., Wilffert, B., & Loonen, A. J. M. (2015). Dissimilar mechanistic background of peripheral and orofacial hyperkinesia in patients with Parkinson's disease and levodopa-induced dyskinesia. Physiology and Pharmacology, 19(4), 216-221. https://www.semanticscholar.org/paper/Dissimilar-mechanistic-background-of-peripheral-and-Ivanova-Fedorenko/cc42b38ddcef4ba728d60a8a39a3cde9b09a6862
  7. Vellinga, N. A. R., Veenstra, G., Scorcella, C., Koopmans, M., van Roon, E. N., Ince, C., & Boerma, E. C. (2015). Effects of ketanserin on microcirculatory alterations in septic shock: An open-label pilot study. Journal of Critical Care, 30(6), 1156-1162. https://doi.org/10.1016/j.jcrc.2015.07.004
  8. Scholl, J. H. G., van de Ven, P. M., & van Puijenbroek, E. P. (2015). Parametric time-to-onset models were developed to improve causality assessment of adverse drug reactions from antidiabetic drugs. Journal of Clinical Epidemiology, 68, 1423-1431. https://doi.org/10.1016/j.jclinepi.2015.03.001
  9. Geurts, M. M. E., Stewart, R. E., Brouwers, J. R. B. J., de Graeff, P. A., & de Gier, J. J. (2015). Patient beliefs about medicines and quality of life after a clinical medication review and follow-up by a pharmaceutical care plan: A study in elderly polypharmacy patients with a cardiovascular disorder. Journal of Pharmaceutical Health Services Research, 6(4), 171-176. https://doi.org/10.1111/jphs.12104
  10. Ter Horst, P. G. J., Proost, J. H., Smit, J. P., Vries, M. T., de Jong-van den Berg, L., & Wilffert, B. (2015). Pharmacokinetics of clomipramine during pregnancy. European Journal of Clinical Pharmacology, 71(12), 1493-1500. https://doi.org/10.1007/s00228-015-1944-6
  11. van der Elst, K. C. M., Brouwers, C. H. S., van den Heuvel, E. R., van Wanrooy, M. J. P., Uges, D. R. A., van der Werf, T. S., Kosterink, J. G. W., Span, L. F. R., & Alffenaar, J-W. C. (2015). Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease. Therapeutic Drug Monitoring, 37(6), 766-771. https://doi.org/10.1097/FTD.0000000000000235
  12. van Hasselt, F. M., Oud, M. J. T., & Loonen, A. J. M. (2015). Gezamenlijke somatische zorg voor patiënten met een ernstige psychische aandoening. Nederlands Tijdschrift voor Geneeskunde, 159(0), A9160.
  13. Buurman, D. J., Maurer, J. M., Keizer, R. J., Kosterink, J. G. W., & Dijkstra, G. (2015). Letter: infliximab therapy for patients with inflammatory bowel disease - some unanswered questions. Authors' reply. Alimentary Pharmacology & Therapeutics, 42(9), 1134-1134. https://doi.org/10.1111/apt.13396
  14. Pont, L. G., Nielen, J. T. H., Mclachlan, A. J., Gnjidic, D., Chan, L., Cumming, R. G., & Taxis, K. (2015). Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures. British Journal of Clinical Pharmacology, 80(5), 1169-1175. https://doi.org/10.1111/bcp.12670
  15. de Vries, S. T., de Vries, F. M., Dekker, T., Haaijer-Ruskamp, F. M., de Zeeuw, D., Ranchor, A. V., & Denig, P. (2015). The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes. PLoS ONE, 10(10), [e0139755]. https://doi.org/10.1371/journal.pone.0139755
  16. van Puijenbroek, E. (2015). Another Perspective in Pharmacovigilance. Drug Safety, 38(10), 944-944.
  17. Tran, Y. H., Wang, H., Bergman, J. E. H., Groen, H., Bakker, M. K., & Wilffert, B. (2015). Drugs acting via vascular disruption and related birth defects: a systematic review. Pharmcoepidemiology and Drug Safety, 24(Suppl. 2:33), 33-33. [P25]. https://doi.org/10.1002/pds.3868
  18. Bolhuis, M. S., Tiberi, S., Sotgiu, G., De Lorenzo, S., Kosterink, J. G. W., van der Werf', T. S., Miglioris, G. B., & Alffenaar, J-W. C. (2015). Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study. European Respiratory Journal, 46(4), 1205-1207. https://doi.org/10.1183/13993003.00606-2015
  19. Rolfes, L., van Hunsel, F., & van Puijenbroek, E. (2015). The Impact of ADRs on Patient's Quality of Life After Packaging Changes of the Drug Thyrax (R). Drug Safety, 38(10), 946-947.
  20. de Jong, L., Harmark, L., & van Puijenbroek, E. (2015). Web-Based Intensive Monitoring of Metformin. Drug Safety, 38(10), 980-980.
  21. Yska, J. P., van Roon, E. N., de Boer, A., Leufkens, H. G. M., Wilffert, B., de Heide, L. J. M., de Vries, F., & Lalmohamed, A. (2015). Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom. JAMA Surgery, 150(12), 1126-1133. https://doi.org/10.1001/jamasurg.2015.2398
  22. Jansen, P. A. F., Brouwers, J. R. B. J., & Van Roon, E. N. (2015). Appropriate choice of drugs in older patients. Nederlands Tijdschrift voor Geneeskunde, 159(45). https://www.ntvg.nl/artikelen/de-juiste-keuze-van-geneesmiddelen-bij-ouderen/
  23. Huong-Thao Nguyen, U., Tuan-Dung Nguyen, N. V., van den Heuvel, E. R., Haaijer-Ruskamp, F. M., & Taxis, K. (2015). Medication Errors in Vietnamese Hospitals: Prevalence, Potential Outcome and Associated Factors. PLoS ONE, 10(9), [e0138284]. https://doi.org/10.1371/journal.pone.0138284
  24. Scholl, J. H. G., Van De Ven, P. M., & Van Puijenbroek, E. P. (2015). Parametric time-to-onset (TTO) modelling of common ADRs in patients using antidiabetic drugs. Pharmacoepidemiology and Drug Safety, 24, 565. https://doi.org/10.1002/pds.3838
  25. Ivanova, S. A., Alifirova, V. M., Fedorenko, O. Y., Freidin, M. B., Bokhan, N. A., Zhukova, I., Al Hadithy, A. F. Y., Brouwers, J. R. B. J., Wilffert, B., & Loonen, A. J. M. (2015). Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease. European Neuropsychopharmacology, 25(Supplement 2), S589. [Abstract poster]. https://doi.org/10.1016/S0924-977X(15)30828-2
  26. Dijkstra, J. A., van Altena, R., Akkerman, O. W., de Lange, W. C. M., Proost, J. H., van der Werf, T. S., Kosterink, J. G. W., & Alffenaar, J. W. C. (2015). Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis. International journal of antimicrobial agents, 46(3), 332-337. https://doi.org/10.1016/j.ijantimicag.2015.06.008
  27. Simoons, M., Mulder, H., Van Roon, E. N., & Ruhe, H. G. (2015). Medication discrepancies in outpatients with mood and anxiety disorders. Risks and clinical relevance. European Neuropsychopharmacology, 25, S454. https://www.medscape.com/viewcollection/33450
  28. Buurman, D. J., Maurer, J. M., Keizer, R. J., Kosterink, J. G. W., & Dijkstra, G. (2015). Population pharmacokinetics of infliximab in patients with inflammatory bowel disease: potential implications for dosing in clinical practice. Alimentary Pharmacology & Therapeutics, 42(5), 529-539. https://doi.org/10.1111/apt.13299
  29. de Vries, D., Hak, E., & Postma, M. J. (2015). The Impact of Cardiovascular Risk, Baseline LDL-Cholesterol, Treatment Dose and Adherence on Cost-Effectiveness of Statins in Newly Diagnosed Diabetes Patients. Pharmcoepidemiology and Drug Safety, 24, 37-38. https://doi.org/10.1002/pds.3838
  30. van Leent, M. W. J., Stevanovic, J., Jansman, F. G., Beinema, M. J., Brouwers, J. R. B. J., & Postma, M. J. (2015). Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data. PLoS ONE, 10(8), [e0135054]. https://doi.org/10.1371/journal.pone.0135054
  31. Schutte, T., Tichelaar, J., Reumerman, M. O., Van Eekeren, R., Rolfes, L., Richir, M. C., Van Puijenbroek, E., & Van Agtmael, M. A. (2015). Learning by doing in the student-run pharmacovigilance program. 79.
  32. Jessurun, N. T., Van Hunse, F., & Van Puijenbroek, E. (2015). Metabolic acidosis with a high anion: A drug-drug interaction between paracetamol and flucloxacillin. 47. http://www.lareb.nl/Publicaties/2015_3_parac_fluclox_CT.aspx
  33. Schutte, T., Tichelaar, J., Reumerman, M. O., Van Eekeren, R., Groenland, S., Rolfes, L., Richir, M. C., Van Puijenbroek, E., & Van Agtmael, M. A. (2015). Student views on the student-run pharmacovigilance program. 156-157.
  34. van der Paardt, A-F., Wilffert, B., Akkerman, O. W., de Lange, W. C. M., van Soolingen, D., Sinha, B., van der Werf, T. S., Kosterink, J. G. W., & Alffenaar, J-W. C. (2015). Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis. European Respiratory Journal, 46(2), 444-455. https://doi.org/10.1183/09031936.00147014
  35. Kamphuis, J., Taxis, K., Schuiling-Veninga, C. C. M., Bruggeman, R., & Lancel, M. (2015). Off-Label Prescriptions of Low-Dose Quetiapine and Mirtazapine for Insomnia in The Netherlands. Journal of Clinical Psychopharmacology, 35(4), 468-470. https://doi.org/10.1097/JCP.0000000000000338
  36. Sturkenboom, M. G. G., Mulder, L. W., de Jager, A., van Altena, R., Aarnoutse, R. E., de Lange, W. C. M., Proost, J. H., Kosterink, J. G. W., van der Werf, T. S., & Alffenaar, J-W. C. (2015). Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis. Antimicrobial Agents and Chemotherapy, 59(8), 4907-4913. https://doi.org/10.1128/AAC.00756-15
  37. Berm, E. J. J., Ruijsbroek, R., Loonen, A. J. M., Goethals, K. R., Wilffert, B., & van Hasselt, F. (2015). Overstap op e-sigaret beïnvloedt medicijnconcentratie. Nederlands Tijdschrift voor Geneeskunde, 159(0), A9090.
  38. Maurer, J. M., Schellekens, R. C. A., van Rieke, H. M., Wanke, C., Iordanov, V., Stellaard, F., Wutzke, K. D., Dijkstra, G., van der Zee, M., Woerdenbag, H. J., Frijlink, H. W., & Kosterink, J. G. W. (2015). Gastrointestinal pH and Transit Time Profiling in Healthy Volunteers Using the IntelliCap System Confirms Ileo-Colonic Release of ColoPulse Tablets. PLoS ONE, 10(7), [e0129076]. https://doi.org/10.1371/journal.pone.0129076
  39. Hazen, A. C. M., Sloeserwij, V. M., Zwart, D. L. M., de Bont, A. A., Bouvy, M. L., de Gier, J. J., de Wit, N. J., & Leendertse, A. J. (2015). Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT). BMC Family Practice, 16, 76. https://doi.org/10.1186/s12875-015-0296-8
  40. Daud, A. N. A., Bergman, J. E. H., Bakker, M. K., Wang, H., Kerstjens-Frederikse, W. S., de Walle, H. E. K., Groen, H., Bos, J. H. J., Hak, E., & Wilffert, B. (2015). P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study. Drug Safety, 38(7), 651-659. https://doi.org/10.1007/s40264-015-0299-3
  41. Daskapan, A., Stienstra, Y., Akkerman, O. W., de lange, W. C. M., Kosterink, J. G. W., van der Werf, T. S., & Alffenaar, J-W. C. (2015). The Never Ending Struggle Against Development of Drug Resistance. Clinical Infectious Diseases, 61(1), 137-138. https://doi.org/10.1093/cid/civ238
  42. Helmons, P. J., Suijkerbuijk, B. O., Nannan Panday, P. V., & Kosterink, J. G. W. (2015). Doing the right things and doing things right: inpatient drug surveillance assisted by clinical decision support. European Journal of Hospital Pharmacy: Science and Practice, 22(4), 236-242. https://doi.org/10.1136/ejhpharm-2014-000505
  43. Helmons, P. J., Suijkerbuijk, B. O., Nannan Panday, P., & Kosterink, J. G. W. (2015). Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis. Journal of the American Medical Informatics Association, 22(4), 764-772. https://doi.org/10.1093/jamia/ocu010
  44. Martono, D. P., Lub, R., Heerspink, H. J. L., Hak, E., Wilffert, B., & Denig, P. (2015). Predictors of response in initial users of metformin and sulphonylurea derivatives: A systematic review. Diabetic Medicine, 32(7), 853-864. https://doi.org/10.1111/dme.12688
  45. Degenhardt, C., Hoppe-Tichy, T., Kantelhardt, P., Picksak, G., Schnurrer, J. U., & Taxis, K. (2015). Große Kunst: Trockensaft richtig herstellen. Krankenhauspharmazie, 36(6), 308-309.
  46. Van Leeuwen, R. W. F., Mathijssen, R. H. J., Jansman, F. G. A., & Van Gelder, T. (2015). Reply to the letter to the editor 'Potential clinical relevant drug-drug interactions: Comparison between different compendia, do we have a validated method?' by Conde-Estévez et al. Annals of Oncology, 26(6), 1272-1273. https://doi.org/10.1093/annonc/mdv169
  47. Berhe, D. F., Juhlin, K., Star, K., Beyene, K. G. M., Dheda, M., Haaijer-Ruskamp, F. M., Taxis, K., & Mol, P. G. M. (2015). Adverse Drug Reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase. Tropical Medicine & International Health, 20(6), 797-806. https://doi.org/10.1111/tmi.12481
  48. Kamal, R. M., Loonen, A., Dijkstra, B. A. G., & De Jong, C. A. J. (2015). Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence: A case series. Journal of Clinical Psychopharmacology, 35(3), 313-318. https://doi.org/10.1097/JCP.0000000000000315
  49. Mol, P. G. M., Arnardottir, A. H., Straus, S. M. J., de Graeff, P. A., Haaijer-Ruskamp, F. M., Quik, E. H., Krabbe, P. F. M., & Denig, P. (2015). Understanding drug preferences, different perspectives. British Journal of Clinical Pharmacology, 79(6), 978-987. https://doi.org/10.1111/bcp.12566
  50. Berm, E. J., Gout-Zwart, J. J., Luttjeboer, J., Maring, J. G., Wilffert, B., & Postma, M. J. (2015). Cost-effectiveness of Cyp2d6 genotyping in older depressed patients, starting with nortriptyline therapy. Value in Health, 18(3), 107.
  51. Nguyen, T. P., Postma, M. J., & Veninga, C. (2015). Health utilities of hypertensive patients in Vietnam. Value in Health, 18(3), 144-145.
Previous 1 2 3 4 5 6 7 8 ...25 Next

ID: 32723

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube